September 6, 2022 — Dr. Sherman brings over thirty years of experience in the scientific instrument industry, including work with Micromeritics Instrument Corporation, ThermoFisher Scientific, and Mettler-Toledo.
September 1, 2022 — We anticipate that our OTCQB listing will provide greater liquidity and a more seamless trading experience for our U.S. shareholders.
August 13, 2022 —We are deploying our unique technology platforms to resolve critical bottlenecks in the chemical and pharmaceutical industry.
August 10, 2022 — We created a proof-of-concept robotic workflow leveraging our proprietary in-situ analytical technology and automation tools.
July 13, 2022 — Telescope will initially work on developing CO2 utilization and sequestration technology.
June 27, 2022 — The Direct Inject Liquid Chromatography (“DILC”) platform is an innovative instrument for real-time, immediate analysis of chemical reactions.
April 29, 2022 — Shareholders elected Prof. Jason Hein, Robert Mintak, James Andrew Robinson, Ali Pejman, and Henry Dubina as directors of the Company.
April 26, 2022 — Henry Dubina, the ex-president and strategic business unit head of Mettler-Toledo Autochem, is expected to be nominated as an independent director of Telescope.
Telescope Launches Strategic Division for Industrial Chemical Manufacturing and Announces First Client
April 25, 2022 — “Telescope Industries” is a division of the Company dedicated to resolving process and manufacturing inefficiencies in the chemical industry. For its first project, Telescope Industries has been engaged by Hatch Ltd., a global engineering, project management, and professional services firm.
March 14, 2022 — Positive results from these studies could warrant preclinical development of Telescope’s proprietary compounds as next-generation psychedelic therapeutics.